SCHEMBL17127350

SCHEMBL17127350

CCOCCSC(C(=O)c1ccc(Oc2ccc3cc(OC)ccc3c2)cc1OC)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.39
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ APP P05067 2/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ AKR1C3 P42330 3/20 0.37
▸ AKR1C2 P52895 3/20 0.37
▸ ABCG2 Q9UNQ0 2/20 0.37
▸ AKR1C1 Q04828 1/20 0.37
▸ PTGS1 P23219 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ TNFRSF1A P19438 1/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17127353 0.95 HIF1A (0.40) HIF1APDE4APDE4BPDE4CPDE4D
SCHEMBL17126862 0.87 AKR1C3 (0.39) AKR1C3AKR1C2AKR1C1PTGS1LMNA
SCHEMBL17127328 0.86 CDC25B (0.37) APPAKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL17126864 0.84 SCN9A (0.33) TP53NPC1AKR1C3AKR1C2AKR1C1
SCHEMBL17126857 0.82 APP (0.36) HIF1AAPPNPC1MAPTMEN1
SCHEMBL17126975 0.81 TTR (0.39) HIF1AAPPNPC1MAPTMEN1
SCHEMBL17126861 0.80 CNR1 (0.39) NPC1RAB9A
SCHEMBL17126983 0.79 SMN1; SMN2 (0.36) NPC1MAPTMEN1KMT2ALMNA
SCHEMBL17126973 0.79 SMN1; SMN2 (0.43) MAPTHDAC3HDAC1HDAC2MEN1
SCHEMBL17127022 0.78 PTGS2 (0.38) NPC1MEN1RAB9AKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS HIF1A 3192/4885PDE4A 4160/4885PDE4B 3759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback